Cronos' Shares Plummet On Q3 Financial Report Delay Due To Pending Impairment Charge For U.S. CBD Activities
Cannabis company Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) had to delay filing third-quarter earnings due to pending impairment charge for its U.S. CBD activities. The Toronto-based company revealed Tuesday it has filed a Form 12b-25 with the U.S.
